• Evaluating Sonrotoclax Alone and Combined with Zanubrutinib for Patients with Previously Untreated or Relapsed/Refractory Waldenström Macroglobulinemia

    Not recruiting

    2 1 1
    France Greece Italy Spain
  • Study of Bimekizumab for Children and Adolescents with Moderate to Severe Hidradenitis Suppurativa

    Not recruiting

    3 1 1
    Investigated diseases:
    Investigated drugs:
    Germany Poland
  • Study on the Effects and Safety of Coramitug for Patients with Transthyretin Amyloid Cardiomyopathy (ATTR CM)

    Not recruiting

    2 1
    Investigated diseases:
    Czechia France Germany Italy The Netherlands Portugal +1
  • Study on IMVT-1402 for Patients with Active Cutaneous Lupus Erythematosus

    Not recruiting

    2 1
    Investigated diseases:
    Investigated drugs:
    Bulgaria Germany Greece Poland Spain
  • Study on the Effects of CAL101 for Patients with Idiopathic Pulmonary Fibrosis

    Not recruiting

    2 1 1
    Investigated diseases:
    Investigated drugs:
    Denmark France Italy The Netherlands Norway Romania +1
  • Study on the Effectiveness and Safety of EYE103 Compared to Ranibizumab for Patients with Diabetic Macular Edema

    Not recruiting

    4 1 1 1
    Investigated diseases:
    Austria Croatia Czechia France Germany Hungary +6
  • Study on the Effects and Safety of ALXN2220 for Adults with Transthyretin Amyloid Cardiomyopathy

    Not recruiting

    2 1 1
    Investigated diseases:
    Investigated drugs:
    France Germany The Netherlands Spain
  • Study of Tarlatamab Treatment in Patients with Small Cell Lung Cancer: Evaluation of Different Dosing Schedules

    Not recruiting

    2 1 1 1
    Investigated diseases:
    Investigated drugs:
    Belgium France Germany Greece Italy Spain
  • Study on BJT-778 for Patients with Chronic Hepatitis Delta Infection

    Not recruiting

    4 1 1
    Investigated diseases:
    Investigated drugs:
    Bulgaria
  • Study on the Safety and Immune Response of a High-Dose Influenza Vaccine in Adults Aged 60 and Over, Comparing Trivalent Influenza Vaccine with a Drug Combination

    Not recruiting

    3 1 1 1
    Belgium Bulgaria Estonia Finland Spain

powered by